|
Drug Therapy
Citations 21-30 of 297 total displayed.
|
Past content
(since Feb 1998):
|
- Clinical Sciences
Microscopic Scleral Invasion in Retinoblastoma: Clinicopathological Features and Outcome
- Adriana Cuenca; Flor Giron; Daisy Castro; Adriana Fandiño; Myriam Guitter; María T. G. de Dávila; Guillermo Chantada
Arch Ophthalmol 2009; 127: 1006-1010.
[Abstract]
[Full text]
[PDF]
- Clinical Sciences
Aberrant Wound-Healing Response in Mitomycin C–Treated Leaking Blebs: A Histopathologic Study
- Victor M. Elner; Paula Anne Newman-Casey; A. Jayaprakash Patil; Andrew Flint; Jyotirmay Biswas; Sayoko E. Moroi; Vaijayanthi Pushparaj; Deepak P. Edward
Arch Ophthalmol 2009; 127: 1036-1042.
[Abstract]
[Full text]
[PDF]
- Laboratory Sciences
Subconjunctival Nanoparticle Carboplatin in the Treatment of Murine Retinoblastoma
- Shin J. Kang; Chandrasekar Durairaj; Uday B. Kompella; Joan M. OBrien; Hans E. Grossniklaus
Arch Ophthalmol 2009; 127: 1043-1047.
[Abstract]
[Full text]
[PDF]
- Research Letters
Retinoma Underlying Retinoblastoma Revealed After Tumor Response to 1 Cycle of Chemotherapy
- Helen Dimaras; Vikas Khetan; William Halliday; Elise Héon; Helen S. L. Chan; Brenda L. Gallie
Arch Ophthalmol 2009; 127: 1066-1068.
[Extract]
[Full text]
[PDF]
- Research Letters
Durable Response to Chemotherapy for Recurrent Squamous Cell Carcinoma of the Cheek With Perineural Spread
- Robert Phan; Laura Phan; Lawrence E. Ginsberg; George Blumenschein; Michelle D. Williams; Bita Esmaeli
Arch Ophthalmol 2009; 127: 1074-1075.
[Extract]
[Full text]
[PDF]
- Research Letters
Atypical Infectious Nodular Scleritis
- Muge R. Kesen; Deepak P. Edward; Narsing A. Rao; Joel Sugar; Howard H. Tessler; Debra A. Goldstein
Arch Ophthalmol 2009; 127: 1079-1080.
[Extract]
[Full text]
[PDF]
- Clinical Sciences
Modalities to Decrease Stromal Herpes Simplex Keratitis Reactivation Rates
- John D. Sheppard; Michael L. Wertheimer; Stephen V. Scoper
Arch Ophthalmol 2009; 127: 852-856.
[Abstract]
[Full text]
[PDF]
- Laboratory Sciences
Amelioration of Murine Dry Eye Disease by Topical Antagonist to Chemokine Receptor 2
- Sunali Goyal; Sunil K. Chauhan; Qiang Zhang; Reza Dana
Arch Ophthalmol 2009; 127: 882-887.
[Abstract]
[Full text]
[PDF]
- Editorials
Medication Costs Matter
- Alan R. Morse
Arch Ophthalmol 2009; 127: 929-931.
[Extract]
[Full text]
[PDF]
- Research Letters
Evaluating Patient Discomfort, Anxiety, and Fear Before and After Ranibizumab Intravitreous Injection for Wet Age-Related Macular Degeneration
- Paul Yih Seng Chua; Izabela Mitrut; Ana-Marie Armbrecht; Archana Vani; Tariq Aslam; Baljean Dhillon
Arch Ophthalmol 2009; 127: 939-940.
[Extract]
[Full text]
[PDF]
[ eFigure ]
|
|